Subscribe to Newsletter

Drug Discovery

Discovery & Development Drug Discovery

Takeda’s Chinwe Ukomadu and Chris Arendt on Biopharma’s Future

| 3 min read

Takeda experts explore the potential of AI-driven drug discovery and the importance of including diverse patient voices in trial design.

Discovery & Development Clinical Trials

Getting to First-in-Human Fast

| Asma Patel | 3 min read

How to meet the demand for first-in-human clinical trials using fit-for-phase formulation approaches.

Manufacture Bioprocessing - Upstream & Downstream

Just – Evotec Biologics Expands in Europe

Find out more about a new continuous manufacturing facility opened by Just – Evotec Biologics in Toulouse, France.

Discovery & Development Drug Discovery

Immunotherapy and Multiomics: Changing Cancer Prognosis

How immunotherapy could redefine cancer treatment.

Discovery & Development Drug Discovery

The Power of Genetics

| 2 min read

Regeneron’s Gary Herman discusses the future of genetic medicines and the role of new delivery systems.

Discovery & Development Drug Discovery

Herd Mentality, Cell Therapy, and Pharma’s Future

From overcoming herd mentality in research to expanding cell therapy applications in cancer treatment, we explore the future of pharma.

Discovery & Development Drug Discovery

Navigating Solid State Chemistry and Accelerating Drug Development

| René Steendam | 5 min read

New techniques in solid state chemistry are transforming the pharmaceutical landscape in drug formulation and delivery.

Discovery & Development Drug Discovery

A New Therapeutic for ALD

| 4 min read

Exploring the potential of leriglitazone in helping patients with cerebral X-linked adrenoleukodystrophy.

Manufacture Contract Manufacturing Services

Answering the WHO Call for a GBS Vaccine

| 4 min read

The WHO called for an effective maternal GBS vaccine that could protect infants through transplacental transfer of maternal antibodies.

Business & Regulation Digital Technologies

Making a Mark on Rare Diseases

Technological advances are opening up new drug development opportunities for rare diseases.


Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register